Signaling tests better tool for cancer researchers

Wednesday, 3 November 2010, 8:40 am
Article: sticK

Specialised signaling tests better tool for cancer researchers

(sticK - Nov. 3 2010 ) In Greek, the word symansis means ‘signalling’, and it is this use of the term that underpins the business of Symansis (NZ) Ltd, producers of special reagents that indicate whether particular drug compounds are having the desired effect in a cell.

At the moment, the South Canterbury-based company is concentrating on researchers creating drugs to target cancer. Symansis provides an assay that very quickly, within the researcher’s laboratory, can indicate whether the drug is having the desired effect, which usually is to stop what is uncontrolled growth of the cancer cells (a tumour).

The science behind Symansis’ signaling indicators is quite complex, and was originally brought from London to New Zealand by cancer researcher Peter Shepherd, part-owner of the company, and Professor of Cell Signaling at Auckland University’s School of Medical Sciences.

rel="canonical" href=" http://sticknz.net/2010/11/03/specialised-signaling-tests-provide-quicker-and-better-tool-for-cancer-researchers/ target="_blank">Click to read the rest of this story
http://sticknz.net/2010/11/03/specialised-signaling-tests-provide-quicker-and-better-tool-for-cancer-researchers/

For sticK – science, technology, innovation & commercialisation KNOWLEDGE - is a new Wellington based news service concentrating on following the money from ideas to income. Contact editor Peter Kerr at peter.kerr055 @ gmail.com

© Scoop Media

Peter Kerr

Message maker

Writer, communicator, simplifier, storyteller.

Versed in the art and science of translating something complicated into an understandable message.

Contact Peter Kerr

• Email - peterk@punchline.biz
• Mobile - +64 21 0696 040
• Website - www.punchline.biz
• Twitter - @punchlinebiz
• Website - www.sticknz.net
• Linkedin